Sapna Pradyuman Patel

Assistant Professor

  • 1478 Citations
  • 19 h-Index
20092019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Melanoma Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Mutation Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Interleukin-2 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

Adjuvant ipilimumab in high-risk Uveal melanoma

Fountain, E., Bassett, R. L., Cain, S., Posada, L., Gombos, D. S., Hwu, P., Bedikian, A. & Patel, S. P., Jan 1 2019, In : Cancers. 11, 2, 152.

Research output: Contribution to journalArticle

Open Access
Immunotherapy
Neoplasm Metastasis
Phase II Clinical Trials
Clinical Trials, Phase I
Therapeutics
Open Access
Enterocolitis
Immunotherapy
Adrenal Cortex Hormones
Neoplasms
Rheumatology
1 Citation (Scopus)

Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma

Abu-Sbeih, H., Ali, F. S., Qiao, W., Lu, Y., Patel, S. P., Diab, A. & Wang, Y., Apr 2 2019, In : Cancer Immunology, Immunotherapy. 68, 4, p. 553-561 9 p.

Research output: Contribution to journalArticle

Colitis
Melanoma
Survival
Proportional Hazards Models
Diarrhea

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies

Bhatty, M., Kato, S., Piha-Paul, S. A., Naing, A., Subbiah, V., Huang, H. J., Karp, D. D., Tsimberidou, A. M., Zinner, R. G., Hwu, W-J., Javle, M., Patel, S. P., Hu, M. I-N., Varadhachary, G. R., Conley, A. P., Ramzanali, N. M., Holley, V. R., Kurzrock, R., Meric-Bernstam, F., Kwang Chae, Y. & 3 othersKim, K. B., Falchook, G. S. & Janku, F., Feb 1 2019, In : Cancer. 125, 3, p. 463-472 10 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Melanoma
Mitogen-Activated Protein Kinase Kinases
Neoplasms
1 Citation (Scopus)

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

Buchbinder, E. I., Dutcher, J. P., Daniels, G. A., Curti, B. D., Patel, S. P., Holtan, S. G., Miletello, G. P., Fishman, M. N., Gonzalez, R., Clark, J. I., Richart, J. M., Lao, C. D., Tykodi, S. S., Silk, A. W. & McDermott, D. F., Feb 18 2019, In : Journal for immunotherapy of cancer. 7, 1, 49.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma
Interleukin-2
Melanoma
Therapeutics
Pneumonia